The main purpose of the Advancing Botanical Drug Development Act of 2026 is to encourage the development and approval of botanical drugs by providing them with a period of market exclusivity. This means that once a botanical drug is approved by the Food and Drug Administration (FDA), no other similar products can be marketed for 12 years. The goal is to stimulate innovation and investment in the research and development of these natural therapies, which can address complex health issues.